id_pmc	sentence location	highlighted phrase	protein entities found	number of protein entities
6460049	body	In|the|presence|of|L7D|we|increase|the|cluster|size|of|KIR2DL2|/|3|such|that|the|total|number|of|KIR2DL2|/|3|and|SFK|in|the|cluster|remain|the|same|for|all|the|cluster|size|(|Figure|S3|)|(|further|detail|in|the|Supplemental|Material|)|.	L7D|KIR2DL2|SFKs	3
6460049	body	Use|the|HLA|-|C|*|0304|binding|peptide|GAVDPLLAL|,|we|test|a|series|of|peptide|with|the|follow|modification|at|p7|:|GAVDPLRAL|(|L7R|)|,|GAVDPLFAL|(|L7F|)|,|and|GAVDPLDAL|(|L7D|)|(|7|,|25|)|.	HLA|-|C|L7R|L7F|L7D	6
6460049	body	Peptide|binding|for|the|KIR2DL2|construct|be|high|for|L7R|and|low|for|L7F|and|L7D|.	L7R|L7F|L7D	3
6460049	body	(|B|)|Stabilization|of|HLA|-|C|*|0304|after|peptide|load|with|GAVDPLFAL|(|L7F|)|,|GAVDPLRAL|(|L7R|)|,|GAVDPLDAL|(|L7D|)|and|analysis|by|flow|cytometry|use|DT9|antibody|.	HLA|-|C|L7F|L7R|L7D|DT9|antibody	8
6460049	body	Cell|load|with|GAVDPLFAL|(|L7F|)|,|GAVDPLRAL|(|L7R|)|,|GAVDPLDAL|(|L7D|)|be|stain|with|KIR2DL2|-|Fc|to|assess|the|KIR|binding|.	L7F|L7R|L7D|KIR2DL2	4
6460049	body	L7D|behave|as|a|peptide|antagonist|for|both|L7R|and|L7F|,|similar|to|the|p7|aspartate|modified|peptide|for|HLA|-|C|*|0102|(|Figure|3A|and|Figure|S1|)|.	L7D|L7R|L7F|HLA|-|C	6
6460049	body	(|A|,|B|)|Degranulation|of|KIR2DL3+|(|A|)|and|KIR2DL3−|(|B|)|NK|cell|in|response|to|the|p7|variant|of|GAVPDLLAL|,|GAVPDLADAL|(|L7D|)|,|GAVPDLFAL|(|L7F|)|and|GAVPDLRAL|(|L7R|)|.	p7|variants|GAVPDLLAL|L7D|L7F|L7R	6
6460049	body	(|C|)|Degranulation|of|KIR2DL3+|NK|cell|in|response|to|721.221C|*|0304|-|ICP47|cell|incubate|with|different|combination|of|L7D|and|L7R|peptide|.	721.221C|*|0304|L7D|L7R	5
6460049	body	Our|result|show|that|for|all|concentration|of|L7D|test|,|there|be|a|release|of|NK|cell|from|L7R–mediated|inhibition|.	L7D	1
6460049	body	Moreover|,|we|observe|that|a|low|concentration|of|L7R|(|2.5|μM|)|be|enough|to|induce|almost|50|%|NK|cell|inhibition|in|the|absence|of|L7D|as|oppose|to|80|%|in|the|presence|of|L7D|.	L7R|L7D|L7D	3
6460049	body	Furthermore|,|the|change|in|inhibition|due|to|the|combination|of|L7R|and|L7D|be|linear|,|consistent|with|our|previous|peptide|antagonism|datum|for|HLA|-|C|*|0102|(|12|)|.	L7R|L7D|HLA|-|C	5
6460049	body	Thus|,|at|0.625|μM|L7R|there|be|40|%|inhibition|of|KIR2DL3+|NK|cell|in|the|absence|of|L7D|,|but|in|the|presence|of|L7D|this|level|of|inhibition|be|present|at|a|more|than|10|-|fold|great|concentration|of|L7R|(|7.5|μM|)|.	μM|L7R|L7D|L7D|L7R	5
6460049	body	Thus|,|L7D|be|a|weak|KIR|binding|peptide|that|alone|do|not|induce|inhibition|of|KIR2DL3|-|positive|NK|cell|but|disrupt|the|inhibition|drive|by|L7R|.	L7D|L7R	2
6460049	body	L7D|Induce|Reversal|of|Inhibition|Be|Not|Due|to|Peptide|Displacement|To|exclude|the|possibility|that|the|“|antagonism|”|effect|observe|be|due|to|preferential|presentation|of|the|L7D|peptide|,|we|analyze|the|binding|of|peptide|to|MHC|class|I|by|HPLC|.	L7D|MHC|class|I|HPLC	5
6460049	body	Furthermore|,|the|peak|height|show|that|peptide|in|combination|be|similarly|load|onto|HLA|-|C|and|thus|L7D|do|not|significantly|displace|L7R|or|L7D|from|the|cell|surface|.	HLA|-|C|L7D|L7R|L7D	6
6460049	body	721.221C|*|0304|-|ICP47|cell|be|load|with|single|peptide|or|a|combination|of|L7F|+|L7D|or|L7R|+|L7D|.	L7F|L7D|L7R|L7D	4
6460049	body	L7D|Disrupt|KIR|Aggregation|at|the|Immunological|Synapse|We|next|compare|inhibitory|synapse|formation|in|the|presence|of|L7D|,|L7R|,|or|L7R+L7D|.	L7D|L7D|L7R	3
6460049	body	Analysis|of|KIR|receptor|clustering|at|the|immune|synapse|use|a|GFP|-|link|KIR2DL3|protein|,|show|that|L7R|,|but|not|L7D|induce|increase|aggregation|of|KIR2DL3|(|Figure|5A|,|B|)|.	GFP|-|linked|KIR2DL3|protein|L7R|L7D	7
6460049	body	Figure|6|Schematic|representation|of|process|in|Model|1|and|2|:|(|A|)|Inhibitory|KIR|receptor|bind|to|HLA|-|C|molecule|bind|to|inhibitory|(|L7R|,|green|)|or|antagonist|(|L7D|,|orange|)|peptide|.	Inhibitory|KIR|receptors|HLA|-|C|molecules|L7R|L7D	9
6460049	body	The|binding|affinity|of|KIR|to|HLA|-|C|:|L7D|be|four|time|low|than|to|HLA|-|C|:|L7R|.	KIR|HLA|-|C|L7D|HLA|-|C|L7R	9
6460049	body	The|tyrosine|residue|pair|in|ITIM|be|phosphorylate|by|SFK|upon|inhibitory|KIR|bind|to|HLA|-|inhibitory|(|L7R|)|or|–antagonist|(|L7D|)|peptide|ligand|.	ITIMs|SFKs|inhibitory|KIRs|HLA|L7R|–antagonist|(|L7D|)|peptide|ligands	12
6460049	body	This|behavior|be|implement|in|the|simulation|by|increase|the|inhibitory|KIR|cluster|size|but|decrease|the|density|of|KIR|within|the|cluster|as|the|concentration|of|antagonist|peptide|L7D|be|increase|(|see|Figure|S3|)|.	KIRs|L7D	2
6460049	body	Therefore|,|in|our|simulation|as|the|concentration|of|L7D|increase|,|the|same|number|of|KIR|molecule|be|distribute|evenly|in|large|cluster|size|.	L7D|KIR|molecules	3
6460049	body	In|addition|,|the|negative|feedback|in|Model|1|owe|to|the|de|-|phosphorylation|of|ITIM|by|KIR|:|HLA|-|C|-|L7D|bind|phosphatase|SHP1|,|be|decrease|as|the|distance|between|the|KIR|molecule|increase|with|increase|antagonist|concentration|.	ITIMs|KIR|HLA|-|C|L7D|SHP1|KIR|molecules	9
7646483	body	L7D|in|scFv|format|be|express|in|Chinese|hamster|ovary|(|CHO|)|cell|and|characterize|by|analytical|method|,|show|homogeneity|in|size|-|exclusion|chromatography|and|sodium|dodecyl|sulfate|-|polyacrylamide|gel|electrophoresis|(|SDS|-|PAGE|)|(|Figure|1|(|b|,|c|)|)|.	L7D	1
7646483	body	To|confirm|the|cross|-|reactivity|of|L7D|for|the|mouse|antigen|,|BIAcore|analysis|be|perform|on|a|mouse|TNC|domain|BCD|-|coat|chip|(|Figure|1|(|e|)|)|.	L7D|mouse|antigen	3
7646483	body	A|microscopic|immunofluorescence|analysis|on|U87|glioblastoma|section|confirm|that|the|L7D|antibody|could|recognize|its|cognate|antigen|in|tissue|(|Figure|1|(|f|)|)|.Figure|1.Characterization|of|antibody|against|the|human|splice|isoform|D|of|Tenascin|C|(|hTNC|-|D|)|(|a|)|Structural|model|of|one|subunit|of|Tenascin|C.|Structural|domain|:|hexagon|,|Tenascin|assembly|domain|;|ellipsis|,|epidermal|growth|factor|(|EGF|)|like|repeat|;|white|square|,|constant|fibronectin|type|3|homology|repeat|;|gray|square|,|alternatively|splice|fibronectin|type|3|homology|repeat|;|circle|,|fibrinogen|globe|.	L7D|antibody|antibodies|Tenascin|C|Tenascin|C.|Structural|domains|Tenascin|assembly|domain|epidermal|growth|factor|fibronectin|type|3|homology|repeats|fibronectin|type|3|homology|repeats|fibrinogen	26
7646483	body	Characterization|of|L7D|and|R6N|scFv|select|from|ETH|-|2|library|;|(|b|,|g|)|SDS|-|PAGE|,|10|%|gel|in|reduce|(|R|)|and|non|-|reduce|(|NR|)|condition|of|purify|scFv|;|(|c|,|h|)|Size|exclusion|chromatogram|,|the|major|peak|elute|at|about|11.5|mL|correspond|to|the|molecular|weight|of|monomeric|fraction|of|scFv|;|(|d|,|i|)|BIAcore|sensogram|of|monomeric|scFv|on|hTNC|-|D|coat|CM5|chip|;|(|e|,|l|)|BIAcore|sensogram|of|scFv|on|mouse|TNC|-|BCD|domain|coat|CM5|chip|;|(|f|,|m|)|Microscopic|fluorescence|analysis|of|TNC|-|D|on|U87|tumor|section|detect|with|scFv|(|green|,|AlexaFluor|488|)|and|anti|-|CD31|(|red|,|AlexaFluor|594|)|.	L7D|R|hTNC|BCD|domains|TNC|-|D|CD31	9
7646483	body	In|vitro|CDR1|affinity|maturation|of|L7D|scFv|The|bind|property|of|the|L7D|antibody|be|further|improve|use|a|previously|describe|in|vitro|affinity|maturation|methodology.11|Sequence|variability|in|the|complementarity|-|determine|region|1|(|CDR1|)|loop|of|the|antibody|heavy|and|light|chain|be|introduce|.	CDR1|L7D|antibody|CDR1	4
7646483	body	The|cross|-|reactivity|for|the|mouse|antigen|be|further|confirm|by|SPR|(|KD|value|of|3|nM|)|(|Figure|1|(|l|)|)|.Antigen|specificity|be|evaluate|for|L7D|and|R6N|scFv|by|ELISA|.	mouse|antigen|SPR|L7D	4
7646483	body	As|expect|,|L7D|and|R6N|do|not|bind|to|closely|-|related|protein|,|include|the|alternatively|-|splice|extra|-|domain|A|(|EDA|)|and|B|(|EDB|)|of|fibronectin|,|as|well|as|domain|A1|of|TNC|and|recombinant|human|tumor|necrosis|factor|(|Supplementary|Figure|S5|)|.	L7D|R6N|EDA|EDB|fibronectin|TNC	6
7646483	body	Discussion|In|this|work|,|we|describe|the|generation|,|in|vitro|characterization|and|in|vivo|target|property|of|a|novel|antibody|specific|to|domain|D|of|Tenascin|C.|L7D|scFv|be|isolate|by|phage|display|technology|from|ETH|-|2|Gold|library43|and|affinity|mature|in|vitro|by|randomization|of|CDR1|loop|of|antibody|heavy|and|light|chain|.	novel|antibody|Tenascin|C.|L7D|scFv|CDR1	7
7646483	body	R6N|,|together|with|L7D|,|be|subclone|into|the|mammalian|expression|vector|pcDNA|3.1|(|+|)|by|NheI|/|HindIII|restriction|site|,|produce|and|characterize|as|describe|.	R6N|L7D|NheI	3
